Previous Close | 42.29 |
Open | 42.47 |
Bid | 42.58 x 48300 |
Ask | 42.60 x 51100 |
Day's Range | 42.24 - 43.08 |
52 Week Range | 37.95 - 51.56 |
Volume | |
Avg. Volume | 601,771 |
Market Cap | 9.714B |
Beta (5Y Monthly) | 0.28 |
PE Ratio (TTM) | 19.05 |
EPS (TTM) | 2.24 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jan 25, 2017 |
1y Target Est | 47.90 |
HILDEN, Germany & GERMANTOWN, Md., May 19, 2022--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its recently launched, environmentally friendlier QIAwave nucleic-acid extraction kits have received the prestigious ACT Environmental Impact Factor Label from My Green Lab, a non-profit organization dedicated to advancing sustainability in scientific research.
Investors are optimistic about QIAGEN (QGEN), owing to strong international growth and bullish guidance.
The launch of QIAstat-Dx Rise and other advancements to the QIAstat-Dx portfolio are expected to strengthen QIAGEN's (QGEN) syndromic testing solutions.